Agenda Details | ASGCT Annual Meeting

Detailed Program

Saturday, May 20 2023
10:15 AM – 12:00 PM PT

Emerging Opportunities in Cellular Therapies Derived from Stem Cells

Stem cells have the unique ability to both self-renew and differentiate into defined cell lineages. New stem cell-based therapies are now being translated into clinical trials for diverse diseases. In this session, we will cover diverse programs developed from stem cells including the production of hematopoietic stem cells, immune cells, neural progenitors, and pancreatic islet cells.

Session Details

10:15 AM – 12:00 PM - Concourse Hall 152 & 153

Co-Chair

Agnieszka Czechowicz, MD, PhD. Stanford University School of Medicine, CA

10:15 AM – 12:00 PM - Concourse Hall 152 & 153

Co-Chair

Dan Kaufman, MD, PhD. University of California - San Diego, CA

10:16 AM – 10:40 AM - Concourse Hall 152 & 153

iPSC to HSC

Elizabeth Ng, PhD. Murdoch Children's Research Institute, Australia

10:40 AM – 11:05 AM - Concourse Hall 152 & 153

Engineering iPSCs to generate therapeutic T cells

Gay Crooks, MD. David Geffen School of Med at UCLA, CA

11:05 AM – 11:30 AM - Concourse Hall 152 & 153

A combined stem cell and gene therapy approach for the treatment of ALS and other neurological diseases

Clive Svendsen, PhD. Cedars-Sinai Medical Center, Los Angeles, CA

11:30 AM – 11:55 AM - Concourse Hall 152 & 153

Basic and Translational Stem Cells to Tendons

Alice Huang, PhD. Columbia University, NY